EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structural insights into heterohexameric assembly of epilepsy-related ligand–receptor complex LGI1–ADAM22

Takayuki Yamaguchi, Kei Okatsu iD, Masato Kubota, Ayuka Mitsumori, Atsushi Yamagata iD, Yuko Fukata iD, Masaki Fukata iD, Mikihiro Shibata iD, Shuya Fukai iD

eLife · 2025

DOI: 10.7554/elife.105918 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Takayuki Yamaguchi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Graduate School of Science, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: ADAM Proteins, Nerve Tissue Proteins, Protein Multimerization, Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, Ministry of Education, Culture, Sports, Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leucine-rich glioma-inactivated 1 protein (LGI1) is a secreted neuronal protein consisting of the N-terminal leucine-rich repeat (LRR) and C-terminal epitempin-repeat (EPTP) domains. LGI1 is linked to epilepsy, a neurological disorder that can be caused by genetic mutations of genes regulating neuronal excitability (e.g. voltage- or ligand-gated ion channels). ADAM22 is a membrane receptor that binds to LGI1 extracellularly and interacts with AMPA-type glutamate receptors via PSD-95 intracellularly to maintain normal synaptic signal transmission. Structural analysis of the LGI1–ADAM22 complex is important for understanding the molecular mechanism of epileptogenesis and developing new therapies against epilepsy. We previously reported the crystal structure of a 2:2 complex consisting of two molecules of LGI1 and two molecules of the ADAM22 ectodomain (ECD), which is suggested to bridge neurons across the synaptic cleft. On the other hand, multiangle light scattering, small-angle X-ray scattering, and cryo-electron microscopy (cryo-EM) analyses have suggested the existence of a 3:3 complex consisting of three molecules of LGI1 and three molecules of ADAM22. In the previous cryo-EM analysis, many observed particles were in a dissociated state, making it difficult to determine the three-dimensional (3D) structure of the 3:3 complex. In this study, we stabilized the 3:3 LGI1–ADAM22 ECD complex using chemical cross-linking and determined the cryo-EM structures of the LGI1 LRR –LGI1 EPTP –ADAM22 ECD and 3:3 LGI1–ADAM22 ECD complexes at 2.78 Å and 3.79 Å resolutions, respectively. Furthermore, high-speed atomic force microscopy (HS-AFM) visualized the structural features and flexibility of the 3:3 LGI1–ADAM22 ECD complex in solution. We discuss new insights into the interaction modes of the LGI1–ADAM22 higher-order complex and the structural properties of the 3:3 LGI1–ADAM22 complex.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ADAM ProteinsNerve Tissue ProteinsProtein MultimerizationProteinsEpilepsyIntracellular Signaling Peptides and ProteinsHumansModels, MolecularProtein BindingProtein ConformationAnimalsCryoelectron Microscopy

Stichwörter der Autor:innen

ADAM22HS-AFMLGI1assemblycryo-EMepilepsyhumanmolecular biophysicsstructural biology

Substanzen

ADAM ProteinsIntracellular Signaling Peptides and ProteinsNerve Tissue ProteinsLGI1 protein, humanADAM22 protein, humanProteins

Autor:innen und Institutionen

  • Department of Chemistry, Graduate School of Science, Kyoto University, Kyoto, Japan.
  • Laboratory for Protein Functional and Structural Biology, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan.
  • Division of Molecular and Cellular Pharmacology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Division of Neuropharmacology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Institute for Frontier Science Initiative, Kanazawa University, Kanazawa, Japan.
  • WPI Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, Kanazawa, Japan.

ORCID-Profile: Kei Okatsu, Atsushi Yamagata, Yuko Fukata, Masaki Fukata, Mikihiro Shibata, Shuya Fukai

Förderung

  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development
  • Ministry of Education, Culture, Sports, Science and Technology
  • Takeda Science Foundation

Zitieren

APA

Yamaguchi, T., Okatsu, K., Kubota, M., Mitsumori, A., Yamagata, A., Fukata, Y., Fukata, M., Shibata, M., & Fukai, S. (2025). Structural insights into heterohexameric assembly of epilepsy-related ligand–receptor complex LGI1–ADAM22. eLife. https://doi.org/10.7554/elife.105918

Vancouver

Yamaguchi T, Okatsu K, Kubota M, Mitsumori A, Yamagata A, Fukata Y, et al. Structural insights into heterohexameric assembly of epilepsy-related ligand–receptor complex LGI1–ADAM22. eLife. 2025. doi:10.7554/elife.105918

BibTeX
@article{Yamaguchi2025,
  author = {Yamaguchi, Takayuki and Okatsu, Kei and Kubota, Masato and Mitsumori, Ayuka and Yamagata, Atsushi and Fukata, Yuko and Fukata, Masaki and Shibata, Mikihiro and Fukai, Shuya},
  title = {Structural insights into heterohexameric assembly of epilepsy-related ligand–receptor complex LGI1–ADAM22},
  journal = {eLife},
  year = {2025},
  doi = {10.7554/elife.105918}
}
Kostenlos starten →